phi sigma presentation
TRANSCRIPT
![Page 1: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/1.jpg)
Investigation of the cell-counting mechanism response to the “large-cell” phenotype in Drosophila melanogasterPhi Sigma Symposium Presentation Bryston Nham Advisor: Leslie Saucedo, Ph.DSpring 2015
![Page 2: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/2.jpg)
Normal Development of a Cell (Conlon and Raff, 1999)•Cell Growth •Cell cycle progression •Terminal differentiation•Apoptosis
![Page 3: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/3.jpg)
Normal Development of a Cell (Conlon and Raff, 1999)•Cell Growth •Cell cycle progression •Terminal differentiation•Apoptosis
![Page 4: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/4.jpg)
Tumor Development
![Page 5: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/5.jpg)
Cell – Counting Mechanism
•Recent Studies
•Problem
Abnormally large Amount of cells
Apoptosis initiated to decreasetissue size
Large-cell Phenotype:Normal amount of cells
Apoptosis not initiatedto decrease tissue size
![Page 6: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/6.jpg)
Big Biological Question
•Can abnormal tissue growth from the large-cell phenotype be suppressed by forcing these cells into mitosis? •Could an increase the number of cells
possibly alert the cell-counting mechanism?
Pathways and Genes of Interest: Rheb-gene, myc-gene, and PI3K pathway.
![Page 7: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/7.jpg)
Genes and Pathways of Interest
• Rheb/Myc-genes and the PI3K pathway • Overexpression = increase in cell mass with
failure to promote entry into mitosis. • CDC25 or stg (Drosophila melanogaster)• Phosphatase that activates mitotic cyclin-
dependent kinases, which force cells into mitosis.
![Page 8: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/8.jpg)
+Rheb,myc,PI3K+Rheb,myc,PI3K +stg
Cell-Cycle Diagram
No entry in mitosis
![Page 9: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/9.jpg)
= Cell Death (Apoptosis)
Normal Tissue
+Rheb,Myc, or PI3K+Rheb,Myc, or PI3K +stg
Cell-Counting Mechanism
![Page 10: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/10.jpg)
Protocol Performed• UASGal4 driver system: localizes phenotypic effects to certain
region• enGal4: posterior compartment of wing
• Four sets of crosses:
• Wing tissue analysis based on two characteristics:• 1. Size of the posterior compartment• 2. Cell density in each compartment.
• Caspase stain to potentially identify apoptosis.
Wild-type x enGal4
x enGal + stg
Rheb, myc, or PI3K x enGal4
x enGal + stg
![Page 11: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/11.jpg)
![Page 12: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/12.jpg)
Results: Control Crosses enGal4 Anterior
Posterior
enGal4 (+stg) Anterior Posterior
![Page 13: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/13.jpg)
Results: Rheb-gene crosses enGal4,Rheb Anterior Posterior
enGal4,Rheb (+stg) Anterior Posterior
![Page 14: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/14.jpg)
Results: PI3K crosses enGal4, PI3K Anterior
Posterior
enGal4,PI3K (+stg) Anterior Posterior
![Page 15: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/15.jpg)
Results: Myc-crosses enGal4,myc Anterior
Posterior
enGal4,myc (+stg) Anterior Posterior
![Page 16: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/16.jpg)
Figure 4. The introduction of stg to cells overexpressing growth pathways increased the cell density within the posterior compartment. Cell density within a surface area of 40 μm2 in the posterior and anterior compartments. When stg is expressed the cell density in the posterior compartment is very similar to the anterior compartment, indicating an increase in mitotic activity.
enG4,WT enG4/stg,WT myc myc (+stg) Rheb Rheb (+stg) PI3K PI3K (+stg)0
10
20
30
40
50
60
70
80
Posterior Anterior
Cell
Coun
t
![Page 17: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/17.jpg)
Interpretation of Results
• Overexpression of gene or pathway caused an increase in cell size and overall tissue size. • Cells did not enter mitosis
• When stg was introduced to each cross, tissue size decreased, but cell count increased. • Forced entry in mitosis may have alerted cell-
counting mechanism.
![Page 18: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/18.jpg)
Ongoing and Future/Summer Work • Continue antibody staining• Negative controls showed no apoptosis. • Do antibody staining for stg-crosses.
• Verify apoptosis is biological process for decreased tissue size.• Inhibit apoptosis to see growth patterns.
• Look at tumor development from a different biological approach • Mutate a few cells rather than entire region.
![Page 19: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/19.jpg)
References • Chen BJ, Wu YL, Tanaka Y, Zhang W (2014) Small Molecules
Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics. International Journal of Biological Sciences 10(10); 1084-1096.
• Gao Y, et al (2000). Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 404: 897-900.
• Dang CV. (2012) Myc on the Path to Cancer. Cell Press 149 (1): 22-35.
• Cantley, L. (2002) The Phosphoinositide 3-Kinase Pathway. Science 296 (1655).
• Shaw, RJ., Cantley, LC. (2006) Ras, PI(3)K and mTOR signaling controls tumour cell growth. Nature 441: 424-430.
• Nilsson, I., Hoffmann, I., (2000) Cell cycle regulation by the CDC25 phosphatase family. Prog Cell Cycle Res. 4: 107-114.
![Page 20: Phi Sigma Presentation](https://reader036.vdocuments.pub/reader036/viewer/2022062412/58aeab2f1a28ab00708b46e9/html5/thumbnails/20.jpg)
Thank you for your time! Questions?